Statement re Advanced Medical Solutions Group plc

H.B. Fuller Company ("H.B. Fuller")

Statement re Advanced Medical Solutions Group plc ("AMS")

H.B. Fuller notes the recent announcement made by AMS and confirms that on 30 April 2026 it submitted an all-cash proposal for the entire issued and to be issued share capital of AMS. H.B. Fuller is engaged in discussions and due diligence with AMS. Discussions are ongoing, and there can be no certainty that a binding offer will be made, nor as to the terms on which any offer might be made.

H.B. Fuller has been a successful and disciplined acquiror focused on high growth markets with differentiated technology. H.B. Fuller continues to explore opportunities in its M&A pipeline including, but not limited to, other assets in the medical adhesives market.

In accordance with Rule 2.6(a) of the Code, H.B. Fuller is required, by not later than 5.00 p.m. on 18 June 2026, to either announce a firm intention to make an offer for AMS in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Panel on Takeovers and Mergers (the "Panel") in accordance with Rule 2.6(c) of the Code.

This announcement has been made without the prior agreement or approval of AMS.